NUIX Ltd (NXL)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 1.775 |
|---|---|
| 52-week range | 1.070 – 3.125 |
| Return, 1 month / 3 months | −0.3% / +41.4% |
| Return, 1 year / 3 years | −40.0% / +28.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 51 |
| Volatility (1 year) | 71.8% |
| Worst drawdown (1 year) | -64.8% |
| Average daily value traded | 2.52M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nuix makes software for investigating and making sense of large amounts of unstructured digital information. Its tools help organisations collect, search, analyse and review data such as emails, documents and other files, often in the context of legal disputes, regulatory inquiries, investigations and information governance. Customers include law firms, corporations, government agencies and other institutions that need to examine electronic evidence. Nuix is based in Sydney, Australia, and serves clients in many countries around the world.
NUIX Ltd trades under the code NXL on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NUIX Ltd (NXL) trades on the Australian Securities Exchange in Australia. It last closed at AUD 1.775 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 477 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 40.0% and over the last three months it rose 41.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 16.0% | ||
| From 52-week high | -42.2% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 41.4% | ||
| 6-month return | 33.0% | ||
| 12-month return, skipping the last month | -39.9% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 71.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -64.8% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 2.52M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +4.1% |
|---|---|
| 1 month | −0.3% |
| 3 months | +41.4% |
| 6 months | +33.0% |
| 1 year | −40.0% |
| 3 years | +28.6% |
| 5 years | −43.8% |
Signals
| 50-day / 200-day average | 1.781 / 1.531 |
|---|---|
| Golden / death cross (60 days) | Golden, 23 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.098 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.